Alert systems, also known as trigger-based systems, provide a critical advantage over raw data delivery approaches by ...

Merck's $70 billion US investment plan includes a $3 billion facility in Virginia, creating 500 jobs and enhancing ...

Tips for turning transactional outreach into a trusted working relationship.

In a significant stride for chronic disease management, FDA granted approvals for Roche’s lupus nephritis treatment and Novo Nordisk’s cardiovascular-risk-reducing oral semaglutide for adults with ...

Amgen and AstraZeneca’s Tezspire (tezepelumab-ekko) gains FDA approval as an add-on maintenance therapy for patients aged 12 and older with inadequately controlled chronic rhinosinusitis with nasal ...

These issues had contributed to high turnover and low morale. The challenge, then, was not merely to bring structure to the ...

The Priority Review program is a new initiative launched by the current administration. It was first announced in June of this year, where FDA explained that it would use a collaborative tumor board ...

In today’s Pharmaceutical Executive Daily, we explore how antibody-drug conjugate collaborations are moving beyond oncology ...

According to a report from Reuters, the President claimed that these drugs would cost $150 out-of-pocket. As of the time of ...

As the pharmaceutical industry moves beyond rule-based omnichannel marketing, a new era of agentic systems is emerging, in which AI-powered agents collaborate with humans to orchestrate engagement, ...

EMD Serono's agreement with the US government aims to expand IVF therapy access for 10 million women, offering significant ...

Peptilogics Founder, CEO, Jonathan Steckbeck, explained that PLG0206 stands apart from current treatments, while the ...